OXYCODONE WKT oxycodone hydrochloride 20 mg/2 ml solution for injection or infusion, glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wkt oxycodone hydrochloride 20 mg/2 ml solution for injection or infusion, glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium hydroxide; water for injections; sodium chloride; sodium citrate; hydrochloric acid - oxycodone wkt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE WKT oxycodone hydrochloride 10 mg/1 mL solution for injection or infusion glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wkt oxycodone hydrochloride 10 mg/1 ml solution for injection or infusion glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium citrate; sodium hydroxide; sodium chloride; hydrochloric acid; citric acid monohydrate - oxycodone wkt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE WOCKHARDT oxycodone hydrochloride 20 mg/2 mL solution for injection or infusion, glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wockhardt oxycodone hydrochloride 20 mg/2 ml solution for injection or infusion, glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium citrate; water for injections; citric acid monohydrate; sodium hydroxide - oxycodone wockhardt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE WOCKHARDT oxycodone hydrochloride 10 mg/1 mL solution for injection or infusion, glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wockhardt oxycodone hydrochloride 10 mg/1 ml solution for injection or infusion, glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; citric acid monohydrate; water for injections; sodium chloride; sodium hydroxide; sodium citrate - oxycodone wockhardt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE BNM oxycodone hydrochloride 5mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone bnm oxycodone hydrochloride 5mg capsule blister pack

boucher & muir pty ltd - oxycodone hydrochloride, quantity: 5 mg - capsule, hard - excipient ingredients: gelatin; microcrystalline cellulose; iron oxide red; sodium laureth sulfate; titanium dioxide; indigo carmine; iron oxide yellow; magnesium stearate - oxycodone bnm is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE BNM oxycodone hydrochloride 20mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone bnm oxycodone hydrochloride 20mg capsule blister pack

boucher & muir pty ltd - oxycodone hydrochloride, quantity: 20 mg - capsule, hard - excipient ingredients: iron oxide red; magnesium stearate; microcrystalline cellulose; titanium dioxide; indigo carmine; gelatin; sodium laureth sulfate; iron oxide yellow - oxycodone bnm is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE BNM oxycodone hydrochloride 10mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone bnm oxycodone hydrochloride 10mg capsule blister pack

boucher & muir pty ltd - oxycodone hydrochloride, quantity: 10 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; titanium dioxide; microcrystalline cellulose; indigo carmine; magnesium stearate; iron oxide yellow; sodium laureth sulfate - oxycodone bnm is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE VIATRIS oxycodone hydrochloride 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone viatris oxycodone hydrochloride 5 mg tablet blister pack

viatris pty ltd - oxycodone hydrochloride, quantity: 5 mg - tablet, uncoated - excipient ingredients: lactose; microcrystalline cellulose; stearic acid - oxycodone viatris is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE SANDOZ oxycodone hydrochloride 20 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone sandoz oxycodone hydrochloride 20 mg modified release tablet blister pack

sandoz pty ltd - oxycodone hydrochloride, quantity: 20 mg - tablet, modified release - excipient ingredients: hypromellose; copovidone; microcrystalline cellulose; medium chain triglycerides; titanium dioxide; magnesium stearate; maize starch; stearic acid; lactose monohydrate; colloidal anhydrous silica; behenoyl polyoxyglycerides; hydrogenated castor oil; iron oxide red - oxycodone sandoz modified release tablet is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive; and ? requires daily, continuous, long term treatment. oxycodone sandoz modified release tablet is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. oxycodone sandoz modified release tablet is not indicated as an as-needed (prn) analgesia.

OXYCODONE SANDOZ oxycodone hydrochloride 40 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone sandoz oxycodone hydrochloride 40 mg modified release tablet blister pack

sandoz pty ltd - oxycodone hydrochloride, quantity: 40 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; hypromellose; titanium dioxide; lactose monohydrate; colloidal anhydrous silica; hydrogenated castor oil; iron oxide yellow; medium chain triglycerides; magnesium stearate; stearic acid; behenoyl polyoxyglycerides; copovidone; maize starch - oxycodone sandoz modified release tablet is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive; and ? requires daily, continuous, long term treatment. oxycodone sandoz modified release tablet is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. oxycodone sandoz modified release tablet is not indicated as an as-needed (prn) analgesia.